Sun Pharma to buy U.S.-based Dusa for $230 mln

Thu Nov 8, 2012 6:30pm IST

Related Topics

Stocks

   

REUTERS - Sun Pharmaceutical Industries Ltd (SUN.NS) will pay about $230 million for U.S.-based Dusa Pharmaceuticals Inc DUSA.O to gain access to the skin treatment market in the United States and complement the dermatology business of its Taro Pharmaceutical Industries Ltd (TARO.N) subsidiary.

Sun Pharma, India's top drugmaker by market value, draws nearly half of its sales from the United States but sales from Taro, its Israeli unit, have been driving profits in the world's biggest drug market.

"Dusa's business brings us an entry into dermatological treatment devices, where we see good growth opportunities," Sun Pharma Managing Director Dilip Shanghvi said in a statement on Thursday.

Dusa's Levulan combination therapy is approved by the U.S. Food and Drug Administration for treating non-hyperkeratotic actinic keratoses of the face or scalp.

BLU-U, another Dusa technology, is used to treat moderate inflammatory acne vulgaris.

"This acquisition will actually complement Taro's existing business, which has a strong dermatology product range," said Siddhant Khandekar, an analyst at ICICI Direct in Mumbai.

"This was the only area, a growing one, where Sun did not have products in the United States."

Sun, which has a market value of $13.3 billion, will make a tender offer $8 per share in cash for Dusa, a premium of 38 percent to Dusa's closing price on Wednesday.

Sun Pharma's shares have risen 40 percent this year, compared with a 20 percent rise in the Mumbai market index.

While big multinationals such as Abbott Laboratories (ABT.N) and Sanofi SA (SASY.PA) have been buying out Indian drug companies at high valuations, Sun Pharma remains one of only a few Indian drugmakers that has successfully acquired overseas companies and made profits.

Sun Pharma shares closed down 0.54 percent at 696.55 rupees. The company also announced that its net profit fell 46.5 percent in the second quarter.

(Editing by Roshni Menon and Ted Kerr)

FILED UNDER:

Politics

REUTERS SHOWCASE

Fund Raising

Fund Raising

Flipkart raises $700 million in fresh funding.   Full Article 

Reforms Push

Reforms Push

Modi may order insurance, coal reforms if vote delayed - officials.  Full Article 

Reuters Exclusive

Reuters Exclusive

India looks to sway Americans with nuclear power insurance plan  Full Article 

To Boost Growth

To Boost Growth

Crank up public spending to revive growth - chief economic adviser.   Full Article 

Bold Steps

Bold Steps

SpiceJet rescue plan marks bold bet on Indian aviation recovery.   Full Article 

New Airline

New Airline

Tata, Singapore Air venture Vistara to take off on Jan 9.  Full Article 

Online Sales

Online Sales

Knock knock. Who's there? Amazon's best-selling holiday author.  Full Article 

Hacking Attack

Hacking Attack

N.Korea says did not hack Sony, wants joint probe with U.S.  Full Article 

Reuters Poll

Reuters Poll

BSE Sensex to hit 32,980 by December 2015  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage